Page last updated: 2024-08-22
lutetium and mk-1775
lutetium has been researched along with mk-1775 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Béhé, M; Cohrs, S; Grünberg, J; Lindenblatt, D; Pellegrini, G; Schibli, R; Spycher, PR; Terraneo, N; Vukovic, D | 1 |
Other Studies
1 other study(ies) available for lutetium and mk-1775
| Article | Year |
|---|---|
Combination of lutetium-177 labelled anti-L1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: a novel combination against human ovarian carcinoma.
Topics: Animals; Antineoplastic Agents, Immunological; Apoptosis; Cell Line, Tumor; Cell Survival; Disease Models, Animal; DNA Breaks, Double-Stranded; Female; Humans; Immunoconjugates; Lutetium; Mice; Neural Cell Adhesion Molecule L1; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrimidinones; Radioimmunotherapy; Radioisotopes; Xenograft Model Antitumor Assays | 2018 |